tert-Butyl thiazol-2-ylcarbamate

Catalog No. :
ACEQFU321
CAS No. :
170961-15-6
Molecular Formula :
C8H12N2O2S
Molecular Weight :
200.26

IUPAC Name:tert-butyl thiazol-2-ylcarbamate

tert-Butyl thiazol-2-ylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$96.00Login to see priceIn stockInquiry
500g97%$479.00Login to see priceIn stockInquiry
1000g97%$900.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl thiazol-2-ylcarbamate
IUPAC Nametert-butyl thiazol-2-ylcarbamate
MDL No.MFCD09038327
Molecular FormulaC8H12N2O2S
Molecular Weight200.26
SMILESO=C(OC(C)(C)C)NC1=NC=CS1
InChI KeyNCJXQSNROJRSSL-UHFFFAOYSA-N
SynonymCS-W015607 | tert-Butyl Thiazol-2-ylcarbamate | AKOS000279453 | J-524820 | 2-(TERT-BUTOXYCARBONYLAMINO)THIAZOLE | N-Boc-2-aminothiazole, 95% | SCHEMBL14720 | FT-0697815 | SY110260 | 2-(BOC-AMINO)THIAZOLE | AR2546 | N-Boc-2-thiazolamine | MFCD09038327 | A811274 | VGA96115 | Carbamic ac
CAS No.170961-15-6
PubChem CID11858898

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H317
Precautionary Statement(s)
P280

Synthetic Route by SureRoute

1. ACEQFU321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8
  4. Then
  5. ACEQFU321 route product structure diagram
    ACEQFU321170961-15-6 In Stock
Inquiry

2. ACEQFU321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIQUB342 route compound structure diagram
    --
  4. Plus
  5. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8
  6. Then
  7. ACEQFU321 route product structure diagram
    ACEQFU321170961-15-6 In Stock
Inquiry

Comments (0)